Defective and excessive immunities in pediatric diseases

Area of Science:

• Immunology
• Autoimmune Diseases
• Inflammation

Background:

• Autoimmune and inflammatory diseases are typically treated by suppressing immune system overactivity.
• However, these treatments often only manage symptoms and rarely cure the disease.
• Paradoxically, immune hyper-activation can also arise from underlying immune defects, as seen in primary immunodeficiency diseases.

Purpose of the Study:

• To explore the hypothesis that immune defects, rather than solely immune hyper-activation, contribute to inflammatory and autoimmune diseases.
• To propose novel therapeutic strategies that address underlying immune dysfunctions.

Main Methods:

• Review of existing literature on inflammatory diseases, autoimmune disorders, and primary immunodeficiency.
• Analysis of the relationship between immune defects and immune hyper-activation phenotypes.
• Consideration of pathogenetic mechanisms in multifactorial disorders like Crohn's disease and systemic lupus erythematosus.

Main Results:

• Evidence suggests that immune hyper-activation in some autoimmune and inflammatory conditions may be a compensatory response to underlying immune defects.
• This mechanism might be relevant in multifactorial diseases such as Crohn's disease and systemic lupus erythematosus.
• Current therapeutic approaches focusing solely on suppressing hyper-activation may not address the root cause.

Conclusions:

• Novel therapeutic strategies for severe autoimmune and inflammatory disorders should consider targeting underlying immune defects.
• Addressing immune dysfunctions could lead to more curative treatments beyond symptom management.
• Rethinking the pathogenesis of these diseases opens avenues for innovative therapeutic interventions.